proline and Menopause

proline has been researched along with Menopause in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernabucci, V; Cammà, C; Cerami, C; Ciancio, A; Critelli, R; Karampatou, A; Petta, S; Rizzetto, M; Sagnelli, C; Strona, S; Todesca, P; Turco, L; Villa, E	1
Jeong, HJ; Kim, HM; Nam, SY; Yoou, MS	1
Miyoshi, Y; Noguchi, S; Noma, C; Taguchi, T; Tamaki, Y	1
Abesamis, C; Aloia, JF; Cohn, SH; Ellis, K; Zanzi, I	1
Avioli, LV; Bigazzi, S; Civitelli, R; Gennari, C; Gonnelli, S; Vattimo, A; Zacchei, F	1
Courvoisier, B; Kocher, P; Langer, B; Rovarino, D	1

Trials

1 trial(s) available for proline and Menopause

Article	Year
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women. World journal of gastroenterology, 2014, Nov-28, Volume: 20, Issue:44 Topics: Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Italy; Logistic Models; Menopause; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load	2014

Article

Year

Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.

World journal of gastroenterology, 2014, Nov-28, Volume: 20, Issue:44

Topics: Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Italy; Logistic Models; Menopause; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load

2014

Other Studies

5 other study(ies) available for proline and Menopause

Article	Year
Efficacy of proline in the treatment of menopause. Experimental biology and medicine (Maywood, N.J.), 2016, Volume: 241, Issue:6 Topics: Administration, Oral; Animals; Disease Models, Animal; Female; Humans; Menopause; Mice, Inbred BALB C; Models, Biological; Osteoporosis, Postmenopausal; Proline; Treatment Outcome	2016
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Cancer letters, 2004, Jul-16, Volume: 210, Issue:2 Topics: Adult; Aged; Arginine; Breast Neoplasms; Case-Control Studies; Codon; DNA Mutational Analysis; Female; Genes, p53; Genetic Predisposition to Disease; Humans; Japan; Menopause; Middle Aged; Polymorphism, Genetic; Proline; Receptors, Estrogen; Risk Factors	2004
Hydroxyproline peptides and bone mass in postmenopausal and osteoporotic women. The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:2 Topics: Body Height; Body Surface Area; Body Weight; Bone and Bones; Female; Humans; Menopause; Osteoporosis; Peptides; Proline	1978
Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. The Journal of clinical investigation, 1988, Volume: 82, Issue:4 Topics: Aging; Biomarkers; Bone Resorption; Calcitonin; Calcium-Binding Proteins; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Minerals; Osteocalcin; Osteoporosis; Proline	1988
[Disorders of osseous metabolism in hyperthyroidism]. Helvetica medica acta. Supplementum, 1966, May-15, Volume: 46 Topics: Adolescent; Adult; Aged; Bone Diseases; Calcium; Female; Humans; Hyperthyroidism; Male; Menopause; Middle Aged; Osteomalacia; Osteoporosis; Phosphorus; Proline	1966